Zero or negative interest rates incentivise risky investing and many are putting money into higher-risk asset classes for the first time in pursuit of returns

Data compiled by Enterprise Singapore showed amount raised rose more than five times from the $86 million in 2016 to $464 million last year

In a sector long regarded as a hotbed of mergers and acquisitions, the total value of deals struck this year hit $81 billion, a third lower than 2020

Ractopamine is permitted for use in food producing animals in more than 20 countries, including Australia, the US, Canada and Japan

Shares plunged nearly 20% on Wednesday after a report that Washington was considering blacklisting Chinese biotechnology groups

The study tested antibody levels of 25 recipients of CoronaVac vaccine and found none had sufficient antibodies to neutralise the new strain

Beijing-based biotechnology company develops and commercialises immune-oncology and molecularly-targeted cancer treatment drugs

Kunming-based company to expand its pneumonia vaccine production capacity with an investment of 695 million yuan ($109m)

More avian flu cases have been seen in the Asia-Pacific region, but also in Africa and Europe during the past year

Founded in 2009 and headquartered in Hangzhou, Venus Medtech is a leader in transcatheter heart valvular therapies in China

The share sale, a combination of new and existing shares, is likely to value the maker of medicinal skin care treatments at 19 billion yuan, or $3 billion

Long-anticipated commercialisation of GM corn in the world's No. 2 producer is set to significantly boost yields, reducing the need for imports, firm claims